Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Positive Phase 1 Data Announced for Ebola Vaccine Regimen

April 20, 2016 8:40 am | News | Comments

The Phase 1 study tested a vaccine regimen containing two components.


Pandemic E. Coli Strain H30 Cloaks Its Stealth Strategies

April 20, 2016 8:36 am | by UW Medicine | News | Comments

The bacterium E. coli comes in many different varieties.


Merck’s Keytruda Shows Promise for Merkel Cell Carcinoma

April 19, 2016 4:20 pm | by Stephanie Guzowski, Editor | News | Comments

The immunotherapy trend continues at this year’s American Association for Cancer Research (AACR) annual meeting in New Orleans.


Drug Target in Rare, Lethal Glandular Cancer Discovered

April 19, 2016 3:21 pm | by Yale University | News | Comments

New data shows that ACC and similar cancers could be treated with already available drugs.


Scientists Propose Treatment for Severe Lung Diseases

April 19, 2016 3:14 pm | by Cincinnati Children's Hospital Medical Center | News | Comments

Researchers are following up their current study with further development of the targeted small molecule they recently discovered.


UnitedHealth Ups 2016 Outlook after Surprisingly Strong 1Q

April 19, 2016 2:44 pm | by Tom Murphy, AP Business Writer | News | Comments

UnitedHealth hiked its 2016 forecast after the nation's largest health insurer topped Wall Street's first-quarter earnings expectations.


Research Opens Door for Monocyte-Based Cell Therapy

April 19, 2016 2:41 pm | by VIB | News | Comments

Using a mouse model for pulmonary alveolar proteinosis, the authors demonstrate that this rare disease can be cured by a single transfer of monocytes.


Pfizer Announces Positive Top Line Results for Phase 3 Ibrance Study

April 19, 2016 1:55 pm | News | Comments

Since its introduction in February 2015, more than 25,000 women have been prescribed IBRANCE by more than 6,000 prescribers in the U.S.


Study Provides Structural Basis for Development of New Antibiotic

April 19, 2016 12:37 pm | by Duke University | News | Comments

Antibiotic-resistant infections are a growing threat to public health.

Molecular Zika Study Finds Possible Target for Tests, Drugs

April 19, 2016 12:32 pm | by University of Minnesota | News | Comments

Identifying NS1 also helps to diagnose infections, and other research teams are eyeing it as a possible target for antiviral drug development.


Precision Prevention of Colorectal Cancer

April 19, 2016 10:15 am | by Fred Hutchinson Cancer Research Center | News | Comments

Precision medicine's public face is that of disease -- and better treatments for that disease through targeted therapies. But precision medicine has an unsung partner that could affect the lives of many more people: Precision prevention.


Study Backs Pancreas Cell Transplants for Severe Diabetes

April 19, 2016 9:52 am | by Lauren Neergaard, AP Medical Writer | News | Comments

Transplants of insulin-producing pancreas cells are a long hoped-for treatment for diabetes - and a new study shows they can protect the most seriously ill patients from a life-threatening complication of the disease, an important step toward U.S. approval.


How Purdue Pharma Helped Spark the Opioid Epidemic

April 19, 2016 9:12 am | by Richard Gunderman, The Conversation | News | Comments

The sources of the opioid epidemic are complex, but one powerful motivator has been the pursuit of profit. 


Hormone Drug Could Cure Asthma, Other Fibrosis-Related Diseases

April 19, 2016 9:00 am | by Monash University | News | Comments

Key to this process is Relaxin’s ability to break down collagen.


Xanthohumol Lowers Cholesterol, Blood Sugar, and Weight Gain

April 19, 2016 8:56 am | by Oregon State University | News | Comments

More research will be required to show safety and efficacy in humans.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.